Tubulis is a series b startup based in Germany. 6 investors tracked on Brouky Intelligence. Data sourced from Brouky Intelligence.
About
Tubulis is developing a pipeline of uniquely matched antibody-drug conjugates (ADCs) to treat a variety of solid tumors, leveraging proprietary platforms to create safer and more effective cancer therapies.
Stage
series-b
Investors
6
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky